Tag: Coronavirus information (COVID-19)
Drug Research
C2 PHARMA Opens Government and Research Access to Safety Stock of DIGOXIN API for Use in Potential COVID-19 Combination Treatment
C2 PHARMA s.a.r.l. (C2P), a Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, is announcing that they will open access to safety stocks...
News
Quidel’s Lyra SARS-CoV-2 Assay Receives Authorization for Expanded Use for Molecular Detection of COVID-19
Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel’s Lyra® SARS-CoV-2 Assay...
News
MIG USA, a North Carolina Company, to Bring Needed Relief Through the Provision of Coronavirus Test Kits
MIG USA, LLC , a High Point, North Carolina company having focus in the biotechnology, pharmaceutical, and clinical research sectors, along with its corporate...
Press Releases
FDA Provides Emergency Use Authorization to PerkinElmer for COVID-19 Testing
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, announced that the U.S. FDA has provided Emergency Use Authorization (EUA) for...
Press Releases
Vir Biotechnology Proceeding with Two Clinical Development Candidates for COVID-19
Vir Biotechnology, Inc announced that it has identified multiple human monoclonal antibody (mAb) development candidates that neutralize SARS-CoV-2, the virus responsible for COVID-19.
“We are...
News
OliX Pharmaceuticals Advances RNAi Approaches to Target Highly Conserved Regions of Coronavirus RNAs
OliX Pharmaceuticals, Inc. , a leading developer of RNA interference (RNAi), announced that it will leverage previous preclinical research for developing siRNA therapeutics in...
Packaging & Labelling
PayCargo launches communication mechanism to meet Covid-19 supply chain challenges
Online payment company PayCargo has launched a free communication mechanism that allows vendors such as airlines, ship terminals, and maritime operators to share key...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read